$-0.03
(Market cap
$1,153 Mln
Recently Viewed
Clear AllMarket cap
$1,153 Mln
Revenue (TTM)
$701 Mln
P/E Ratio
--
P/B Ratio
1.5
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
$0 Mln
ROE
-0.1 %
ROCE
-- %
Industry P/E
--
EV/EBITDA
17.2
Debt to Equity
0.2
Book Value
$16.8
EPS
$-1.5
Face value
--
Shares outstanding
46,674,172
CFO
$566.50 Mln
EBITDA
$813.20 Mln
Net Profit
$-300.70 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Avanos Medical (AVNS)
| 119.8 | 84.2 | 88.6 | 98.6 | -7.3 | -11.3 | -2.5 |
|
BSE Sensex
| -9.5 | 5.5 | -6.0 | -4.3 | 8.7 | 9.9 | 11.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Avanos Medical (AVNS)
| -29.5 | -28.8 | -17.1 | -21.9 | -24.4 | 36.1 | -24.8 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Avanos Medical (AVNS)
|
24.7 | 1,153.3 | 701.2 | -67.9 | -8.3 | -8.5 | -- | 1.5 |
| 7.9 | 5,292.8 | 6,552.2 | -530.2 | -4.1 | -9.2 | -- | 1.0 | |
| 299.5 | 8,082.3 | 2,583.2 | 759.9 | 25.2 | 10.8 | 10.8 | 1.1 | |
| 37.1 | 6,195.5 | 3,436.5 | -8.6 | 2.2 | -0.4 | -- | 2.4 | |
| 121.7 | 7,074.2 | 507.4 | -187.7 | -36.2 | -26.4 | -- | 10.8 | |
| 84.0 | 5,456.9 | 1,541.6 | 233.6 | 21.6 | 21.4 | 24.6 | 5.0 | |
| 178.6 | 9,341.0 | 1,526.9 | -151.5 | 20.0 | -17.1 | 46.6 | 12.9 | |
| 330.6 | 13,067.9 | 1,403.7 | 177.7 | 14.7 | 13.8 | 73.7 | 9.1 | |
| 117.1 | 7,400.2 | 738.3 | 48.9 | 11.4 | 2.4 | 150.8 | 3.5 | |
| 31.5 | 13,623.0 | 6,178.4 | 626.5 | 13.0 | 11.9 | 22.3 | 2.6 |
Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes,... Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including surgical pain and recovery products, which comprise ON-Q and ambIT surgical pain pump, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which provide minimally invasive pain-relieving therapies, such as COOLIEF chronic pain products; and Trident and Esentec RFA radiofrequency ablation products to treat chronic pain conditions. The company markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. Avanos Medical, Inc. was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. The company was incorporated in 2014 and is headquartered in Alpharetta, Georgia. Read more
CEO & Director
Mr. Joseph F. Woody
Interim CEO, Senior VP & Chief Transformation Officer
Mr. Michael C. Greiner CPA
Headquarters
Alpharetta, GA
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Avanos Medical Inc (AVNS) is $24.69 (NYSE) as of 24-Apr-2026 13:44 EDT. Avanos Medical Inc (AVNS) has given a return of -7.28% in the last 3 years.
Since, TTM earnings of Avanos Medical Inc (AVNS) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-7.67
|
0.67
|
|
2024
|
-1.87
|
0.88
|
|
2023
|
-16.91
|
0.85
|
|
2022
|
25.18
|
0.98
|
|
2021
|
267.45
|
1.33
|
The 52-week high and low of Avanos Medical Inc (AVNS) are Rs 24.75 and Rs 9.30 as of 25-Apr-2026.
Avanos Medical Inc (AVNS) has a market capitalisation of $ 1,153 Mln as on 24-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Avanos Medical Inc (AVNS), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.